Windtree Therapeutics Statistics Share Statistics Windtree Therapeutics has 28.66M
shares outstanding. The number of shares has increased by 388.31%
in one year.
Shares Outstanding 28.66M Shares Change (YoY) 388.31% Shares Change (QoQ) 388.6% Owned by Institutions (%) 0% Shares Floating 28.64M Failed to Deliver (FTD) Shares n/a FTD / Avg. Volume n/a
Short Selling Information The latest short interest is 2.6M, so 21.85% of the outstanding
shares have been sold short.
Short Interest 2.6M Short % of Shares Out 21.85% Short % of Float 21.85% Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is -0.17 and the forward
PE ratio is null.
Windtree Therapeutics's PEG ratio is
0.
PE Ratio -0.17 Forward PE n/a PS Ratio 0 Forward PS n/a PB Ratio 0.09 P/FCF Ratio -0.06 PEG Ratio 0
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Windtree Therapeutics.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 0.45,
with a Debt / Equity ratio of 0.18.
Current Ratio 0.45 Quick Ratio 0.45 Debt / Equity 0.18 Debt / EBITDA n/a Debt / FCF -0.12 Interest Coverage -106.46
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-391.93K Employee Count 14 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax 3.69M Effective Tax Rate -206.02%
Stock Price Statistics The stock price has increased by null% in the
last 52 weeks. The beta is 0.63, so Windtree Therapeutics's
price volatility has been higher than the market average.
Beta 0.63 52-Week Price Change n/a 50-Day Moving Average 0.71 200-Day Moving Average 8.93 Relative Strength Index (RSI) 38.37 Average Volume (20 Days) n/a
Income Statement
Revenue n/a Gross Profit n/a Operating Income -25.02M Net Income -5.49M EBITDA n/a EBIT -1.56M Earnings Per Share (EPS) -104.35
Full Income Statement Balance Sheet The company has 1.78M in cash and 1.82M in
debt, giving a net cash position of -43K.
Cash & Cash Equivalents 1.78M Total Debt 1.82M Net Cash -43K Retained Earnings -846.61M Total Assets 26.77M Working Capital -4.88M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -15.4M
and capital expenditures -12K, giving a free cash flow of -15.41M.
Operating Cash Flow -15.4M Capital Expenditures -12K Free Cash Flow -15.41M FCF Per Share -293.14
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
Dividends & Yields WINT does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast Currently there are no analyst rating for WINT.
Price Target $350 Price Target Difference n/a Analyst Consensus Hold Analyst Count 1
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Feb 21, 2025. It was a
backward
split with a ratio of 1:50.
Last Split Date Feb 21, 2025 Split Type backward Split Ratio 1:50
Scores Altman Z-Score -46.07 Piotroski F-Score 1
